DERMATOLOGICALS IN THE US

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Dermatologicals Faces Increasing Competition From Natural Alternatives

A Shift Towards Prevention Leads To An Overlap With Beauty and Personal Care

Cold Sore Treatments and Topical Germicidals/antiseptics Push Growth

Competitive Landscape

Chattem (sanofi) Sees Success in Antipruritics

Doctor Recommendations Are Key in the Success of Neosporin Plus

the Strong Cold and Flu Season Contributes To Growth in Cold Sore Treatments

Category Data

Table 1 Sales of Dermatologicals by Category: Value 2013-2018

Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018

Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018

Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018

Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2015-2018

Table 6 Forecast Sales of Dermatologicals by Category: Value 2018-2023

Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023

Executive Summary

Players Innovate To Follow Consumers' Changing Lifestyles

Positive Growth in 2018, Although at A Slower Pace

A Fragmented Competitive Environment

the Move Towards Internet Retailing

Continued Growth for Consumer Health, Despite Maturity and Concern About Changes

Market Indicators

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 9 Life Expectancy at Birth 2013-2018

Market Data

Table 10 Sales of Consumer Health by Category: Value 2013-2018

Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format: % Value 2013-2018

Table 16 Distribution of Consumer Health by Format and Category: % Value 2018

Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements (vds) Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Summary 1 OTC: Switches

Sources

Summary 2 Research Sources

Although dermatologicals saw a positive performance between 2017 and 2018, gains in some categories were partly offset by losses in others, such as antiparasitics/lice (head and body) treatments, vaginal antifungals and nappy (diaper) rash treatments. Within antiparasitics/lice treatments, parents are eschewing medication-based treatments for either natural, herbal solutions or private businesses that specialise in lice removal in the home. In nappy (diaper) rash treatments, fears surrounding th...

Euromonitor International's Dermatologicals in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.